AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2012
May 31, 2012
31542_dirs_2012-05-31_c310ea0e-64ac-4f7a-a956-8f67b35f9be2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2012-05-30
Reporting Person: MCENANY PATRICK J (Director, President and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-30 | Common Stock, par value $0.001 per share | P | 10000 | $0.579 | Acquired | 3218797 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.001 per share | 145922 | Indirect |
Footnotes
F1: Shares are owned by the Reporting Person's spouse.
More from CATALYST PHARMACEUTICALS, INC.
M&A Activity
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Earnings Release
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6